All donanemab articles
-
Opinion
Letters: September 2023
Readers estimate the contribution of lithium mining on power consumption, consider Alzheimer’s antibody therapies and more
-
Business
Antibodies face Alzheimer’s reality
Companies are convincing regulators, but will doctors use them, and will providers pay for them?